Search

Your search keyword '"Bernard Bizzini"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Bernard Bizzini" Remove constraint Author: "Bernard Bizzini"
Sorry, I don't understand your search. ×
106 results on '"Bernard Bizzini"'

Search Results

1. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer

2. IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model

Catalog

Books, media, physical & digital resources

3. Les kinoïdes

4. Early and long-lasting protection from arthritis in tumour necrosis factor (TNF ) transgenic mice vaccinated against TNF

5. Control of allergic reactions in mice by an active anti-murine IL-4 immunization

6. Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases

7. Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia

8. HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes

9. Active Anti-Interferon-α Immunization: A European-Israeli, Randomized, Double-Blind, Placebo-Controlled Clinical Trial in 242 HIV-1-Infected Patients (the EURIS Study)

10. Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC)

11. A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid

12. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids*1

13. C-C chemokines, pivotal in protection against HIV type 1 infection

14. Biological effect of active anti-IFNα immunization in HIV-infected patients

15. Probiotics and oral health

16. Involvement of α-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment

17. Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activation

18. Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS

19. IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells

20. Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS

21. Adjuvants — a balance between toxicity and adjuvanticity

22. The effect of tetanus toxin on in vitro synaptogenesis

23. Usefulness of influenza vaccination in the elderly

24. IFNα kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS

25. Anti-IFNα immunization raises the IFNα-neutralizing capacity of serum — an adjuvant to antiretroviral tritherapy

26. [Kinoids: a novel generation of specific immune therapy against cytokines]

27. A dot-elisa intended for the specific and simultaneous detection of antibodies directed to antigens derived from toxoplasma gondii, rubella virus, cytomegalovirus, and type 1 and type 2 herpesviruses

28. Fragment A-B of tetanus toxin does not block neuromuscular transmission in the goldfish

29. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases

30. TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation

31. Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope

32. Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes

33. Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques

34. Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use

35. Pneumococcal vaccination of elderly individuals

36. Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein

37. Lectin production by human T-lymphocytes

38. Tat toxoid as a component of a preventive vaccine in seronegative subjects

39. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS

41. Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals

42. Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report

43. Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies

44. Tetanus toxin inhibits spontaneous quantal release and cleaves VAMP/synaptobrevin

45. Automat: a novel software system for the systematic search for protein (or DNA) similarities with a notable application to autoimmune diseases and AIDS

47. Tetanus Toxin Biotinylation and Localization of Binding Sites in Catecholaminergic Cultures and Granules

48. Skin-window-induced inflammation in breast cancer patients: a study of macrophage migration

49. Tetanus Toxin as a Tool for Investigating the Structural Bases of Neurotropism

50. Induction of various cytokines in mice and activation of the complement system in rats as a part of the mechanism of action of the Corynebacterium granulosum-derived P40 immunomodulator